Purpose: Focal cortical dysplasia type IIb (FCD IIb) lesions are highly epileptogenic and frequently cause pharmacoresistant epilepsy. Complete surgical resection leads to seizure freedom in most cases. However, the term "complete" resection is controversial with regard to the necessity of performing resections of the subcortical zone, which is frequently seen in these lesions on magnetic resonance imaging (MRI). Methods: We retrospectively analyzed 50 epilepsy patients with histologically proven FCD IIb. The extent of surgical resection was determined by SPM5-based coregistration of the preoperative and postoperative MRI scans. Postoperative outcome was analyzed with regard to (1) the completeness of the resection of the cortical abnormality and (2) the completeness of the resection of the subcortical abnormality. Key Findings: Complete resection of the cortical abnormality led to postoperative seizure freedom (Engel class Ia) in 34 of 37 patients (92%), whereas incomplete cortical resection achieved this in only one of 13 patients (8%, p < 0.001). Among the patients with complete cortical resection, 36 had FCDs with a subcortical hyperintensity according to MRI. In this group, complete resection of the subcortical abnormality did not result in a better postoperative outcome than incomplete resection (90% vs. 93% for Engel class Ia, n.s.). Significance: Complete resection of the MRI-documented cortical abnormality in FCD IIb is crucial for a favorable postoperative outcome. However, resection of the subcortical hyperintense zone is not essential for seizure freedom. Therefore, sparing of the subcortical white matter may reduce the surgical risk of encroaching on relevant fiber tracts. In addition, these findings give an interesting insight into the epileptogenic propensity of different parts of these lesions.
机构:
Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med Neuropathol, Los Angeles, CA 90024 USA
Univ Calif Los Angeles, Med Ctr, Dept Neurol, Los Angeles, CA 90024 USAUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
Vinters, Harry V.
;
Palmini, Andre
论文数: 0引用数: 0
h-index: 0
机构:
Pontifica Univ Catolica Rio Grande do Sul, Serv Neurol, Hosp Sao Lucas, Porto Alegre, RS, BrazilUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
Palmini, Andre
;
Jacques, Thomas S.
论文数: 0引用数: 0
h-index: 0
机构:
Great Ormond St Hosp NHS Trust, London, EnglandUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA
Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA
Univ Calif Los Angeles, David Geffen Sch Med, Dept Behav Sci, Los Angeles, CA 90095 USAUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
机构:
Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med Neuropathol, Los Angeles, CA 90024 USA
Univ Calif Los Angeles, Med Ctr, Dept Neurol, Los Angeles, CA 90024 USAUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
Vinters, Harry V.
;
Palmini, Andre
论文数: 0引用数: 0
h-index: 0
机构:
Pontifica Univ Catolica Rio Grande do Sul, Serv Neurol, Hosp Sao Lucas, Porto Alegre, RS, BrazilUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
Palmini, Andre
;
Jacques, Thomas S.
论文数: 0引用数: 0
h-index: 0
机构:
Great Ormond St Hosp NHS Trust, London, EnglandUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA
Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA
Univ Calif Los Angeles, David Geffen Sch Med, Dept Behav Sci, Los Angeles, CA 90095 USAUniv Hosp Erlangen, Dept Neuropathol, DE-91054 Erlangen, Germany